Stivarga
Active substance: regorafenib
regorafenib
Centralised EU authorisationActive
Marketing holder: Bayer Pharma AG
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| US 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3587-7446-a777-40ede3608f2c,01a120c3-93be-7434-a9f8-d1927f22da48,01a120c3-b054-794c-8ddc-69f903cc538a,01a120c3-bae6-72e0-bf48-05c12fc19bd5,01a120c5-16c5-7a45-8092-b99c51390e74;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12093-9732-71ef-94ab-cd3f07499e4a;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/002573
- Registration status
- Active
- ATC code
- L01EX05
Sources
- product · EMA · EMEA/H/C/002573 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002573 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002573 · Verified 2026-10-09